Vanguard Group
AMPE

Vanguard Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Vanguard Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,180
Closed -$602K – 4629
2022
Q3 		$602K Buy
33,180
+5,540
+20% +$194K ﹤0.01% 4163
2022
Q2 		$1.39M Sell
27,640
-3,384
-11% -$252K ﹤0.01% 3970
2022
Q1 		$4.38M Buy
31,024
+259
+0.8% +$37.8K ﹤0.01% 3599
2021
Q4 		$5.26M Sell
30,765
-70
-0.2% -$26.1K ﹤0.01% 3579
2021
Q3 		$15.4M Buy
30,835
+215
+0.7% +$99.7K ﹤0.01% 2998
2021
Q2 		$15.3M Buy
30,620
+5,681
+23% +$3.05M ﹤0.01% 2978
2021
Q1 		$12.6M Buy
24,939
+1,343
+6% +$693K ﹤0.01% 3025
2020
Q4 		$11.3M Buy
23,596
+3,596
+18% +$1.18M ﹤0.01% 2933
2020
Q3 		$5.74M Buy
20,000
+2,185
+12% +$542K ﹤0.01% 3082
2020
Q2 		$3.4M Sell
17,815
-28
-0.2% -$4.66K ﹤0.01% 3258
2020
Q1 		$2.22M Hold
17,843
– – ﹤0.01% 3274
2019
Q4 		$3.12M Buy
17,843
+4
+0% +$517 ﹤0.01% 3321
2019
Q3 		$2.68M Buy
17,839
+2,177
+14% +$290K ﹤0.01% 3354
2019
Q2 		$1.82M Sell
15,662
-296
-2% -$46.9K ﹤0.01% 3503
2019
Q1 		$2.69M Buy
15,958
+1,847
+13% +$316K ﹤0.01% 3355
2018
Q4 		$1.67M Buy
14,111
+1,379
+11% +$212K ﹤0.01% 3428
2018
Q3 		$1.94M Buy
12,732
+1,397
+12% +$584K ﹤0.01% 3542
2018
Q2 		$7.48M Buy
11,335
+1,616
+17% +$1.21M ﹤0.01% 3046
2018
Q1 		$9.91M Buy
9,719
+2,006
+26% +$1.68M ﹤0.01% 2830
2017
Q4 		$9.42M Buy
7,713
+3,356
+77% +$1.58M ﹤0.01% 2847
2017
Q3 		$799K Sell
4,357
-457
-9% -$72.4K ﹤0.01% 3647
2017
Q2 		$753K Sell
4,814
-1,255
-21% -$254K ﹤0.01% 3638
2017
Q1 		$1.46M Buy
6,069
+39
+0.6% +$10.5K ﹤0.01% 3475
2016
Q4 		$1.63M Sell
6,030
-696
-10% -$166K ﹤0.01% 3425
2016
Q3 		$1.49M Buy
6,726
+742
+12% +$208K ﹤0.01% 3471
2016
Q2 		$2.32M Buy
5,984
+413
+7% +$451K ﹤0.01% 3331
2016
Q1 		$3.76M Buy
5,571
+223
+4% +$150K ﹤0.01% 3108
2015
Q4 		$5.62M Buy
5,348
+127
+2% +$126K ﹤0.01% 2935
2015
Q3 		$4.53M Buy
5,221
+196
+4% +$164K ﹤0.01% 3014
2015
Q2 		$3.57M Buy
5,025
+259
+5% +$276K ﹤0.01% 3168
2015
Q1 		$10.8M Buy
4,766
+265
+6% +$452K ﹤0.01% 2615
2014
Q4 		$4.63M Buy
4,501
+135
+3% +$144K ﹤0.01% 2939
2014
Q3 		$4.62M Sell
4,366
-82
-2% -$138K ﹤0.01% 2877
2014
Q2 		$11.1M Buy
4,448
+34
+0.8% +$69.4K ﹤0.01% 2461
2014
Q1 		$8.41M Buy
4,414
+951
+27% +$2.25M ﹤0.01% 2567
2013
Q4 		$7.41M Buy
3,463
+99
+3% +$234K ﹤0.01% 2592
2013
Q3 		$7.57M Buy
3,364
+6
+0.2% +$11.6K ﹤0.01% 2527
2013
Q2 		$5.81M Buy
+3,358
New +$5.33M ﹤0.01% 2582

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Vanguard Group's AMPE Position: Q4 2022 in Review

Vanguard Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 33,180 shares — an estimated $602K sold.

Vanguard Group first reported a position in AMPE in Q2 2013 and held it in 38 quarters. The position peaked at $15.4M in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Vanguard Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 33,180 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $602K.
  • Vanguard Group first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 38 quarters.
  • Vanguard Group's Ampio Pharmaceuticals Inc. position peaked at $15.4M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.